PPT-Platelet Transfusions Indications, dose and administration

Platelet products volume and expected p latelet i ncrement Indications for platelet transfusions Decision to transfuse should be based on both laboratory investigations and assessment of the clinical condition with careful consideration of risks amp benefits . Morey A. Blinder, M.D.. Associate Professor of Medicine. and Pathology & Immunology. Objectives. Coagulation factor disorders and treatment. Disorders of platelets and platelet transfusion. Adjunctive drug therapy for bleeding. Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter. 250,000 – 400,000 per microliter . (too few thrombocytopenia – too many thrombocytosis). Lifespan on average 6 – 10 days. Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter. 250,000 – 400,000 per microliter . (too few thrombocytopenia – too many thrombocytosis). Lifespan on average 6 – 10 days. “Blood transfusion is like marriage: it should not be entered upon lightly, unadvisedly or wantonly or more often than is absolutely necessary. .” . . –Robert Beal, past director of International Federation of Red Cross. Class Starter: . What are the different blood types that exist?. What determines what type of blood you have?. Why can you die if you were to receive an incompatible blood type?. What determines the different blood groups?. INDICATIONS AND USAGE Treatment of Thrombocytopenia in Patients with Chronic Liver Disease (CLD) DOPTELET is indicated for the treatment of thrombocytopenia in adult patients with chronic liver diseas 1 IBING INFORMATION These highlights do not include all the information needed to use DOPTELET safely and effectively. See full prescribing information for DOPTELET . DOPTELET Rachel MossSenior Transfusion PractitionerGreat Ormond Street Hospital NHS Foundation TrustPlatelet Use in Paediatrics and NeonatesThe child first and alwaysDisclaimer 1Im not a Paediatrician2Dr Helen thrombocytopenia. ) constitutes an important cause of generalized bleeding.. A count less than 100,000 platelets/. μL. is generally considered to constitute thrombocytopenia. . Platelet counts in the range of 20,000 to 50,000 platelets/. At the end of this unit of study, the student should be able to:. Describe the normal morphology and number of platelets on a peripheral blood smear and state the normal life span and concentration of platelets in the blood.. Adults 22 years of age and older. Diagnosed OSA with an AHI range of 20-65 per hour. CPAP failure or inability to tolerate CPAP treatment:. PAP failure is defined as an inability to eliminate OSA (AHI of greater than 20 despite PAP usage). INDICATIONS FOR USE PRIMARY FEMORAL PREPARATION PRIMARY FEMORAL PREPARATION REVISION FEMORAL PREPARATION REVISION FEMORAL PREPARATION TIBIAL PREPARATION TIBIAL PREPARATION TRIALING TRIALING IMPLANT AS Ishfaq. . Bukhari. Dec. 2012. In healthy vasculature, circulating platelets are maintained in an inactive state by nitric oxide (NO) and . prostacyclinre. (PGI2)leased by endothelial cells lining the blood vessels.. Workstream. Dr. Brian Tehan. MD for Quality & Transformation. BCUHB. brian.tehan@wales.nhs.uk. Stephanie Ditcham. Blood Health Advisor and Scientific Lead, . North . Wales. ,. Welsh Blood Service.